The influence of nodal size on EUS-FNA outcomes for mediastinal staging of NSCLC Source: Annual Congress 2010 - Are needles enough: the value of different approaches Year: 2010
Intrathoracic lymph node staging of potentially resectable non-small cell lung cancer - The role of PET-CT Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015
Risk factors for occult mediastinal lymph node involvement in clinical stage I lung cancer Source: ISSN=ISSN 1810-6838, ISBN=, page=163 Year: 2007
Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease? Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018 Year: 2019
N3 hilar sampling decision in the staging of mediastinal lung cancer Source: ERJ Open Res, 7 (3) 00116-2021; 10.1183/23120541.00116-2021 Year: 2021
Comparative evaluation of resectability, postoperative morbidity and mediastinal downstaging after cisplatin-based chemoinduction versus radiochemoinduction for stage III non-small cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 214s Year: 2003
Mediastinal lymph node staging with spiral CT and FDG-PET in patients with non-small cell lung cancer (NSCLC). Avoidable thoracotomies Source: Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging Year: 2004
Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer Source: Breathe, 14 (4) 342; 10.1183/20734735.027118 Year: 2018
Accuracy of re-mediastinoscopy and fusion PET-CT in the assessment of lymph node (LN) downstaging after induction chemotherapy for N2 non-small cell lung cancer (NSCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 602s Year: 2006
Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant. A prospective study Source: Eur Respir J 2007; 30: Suppl. 51, 206s Year: 2007
The efficacy of induction chemoradiotherapy followed by surgery in stage IIIA-proven N2 NSCLC and the influence of lymph node downstage on the incidence of postoperative recurrence Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
Results of echoendoscopic ultrasound in mediastinal nodal staging of lung cancer Source: Annual Congress 2012 - Progress in endoscopy for lung cancer Year: 2012
Diagnostic yield, clinical impact and cost aspect of EBUS-TBNA in mediastinal staging in lung cancer Source: Annual Congress 2012 - Progress in endoscopy for lung cancer Year: 2012
Brain metastasis in lung cancer – our 5-year experience Source: Eur Respir J 2004; 24: Suppl. 48, 74s Year: 2004
Usefulness of surgical staging after negative EBUS -staging in patients with lung cancer with clinical N0. Source: International Congress 2019 – General thoracic surgery Year: 2019
Clinical value of 18-FDG PET-CT in mediastinal lymph node staging in non-small cell lung cancer (NSCLC) patients with previous cN0-1 on CT Source: Annual Congress 2007 - Diagnosis of thoracic malignancies Year: 2007
Role of molecular and cellular techniques applied to EBUS-TBNA of mediastinal lymph nodes for lung cancer staging Source: Annual Congress 2012 - EBUS-TBNA: a never ending story Year: 2012
Sampling of ipsilateral mediastinal nodes by EBUS-TBNA in lung cancer staging Source: Annual Congress 2012 - Progress in endoscopy for lung cancer Year: 2012